Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00034294 | A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea | PHASE2 | COMPLETED | 300 | — | — | Feb 1, 2002 | Jul 1, 2003 | Mar 5, 2015 | 99 | United States, Canada +2 |
| Name | Type | Description |
|---|---|---|
| GT160-246 | DRUG | - |
Inclusion Criteria: * Be at least 18 years old. * Have active mild to moderate C. difficile- Associated Diarrhea (CDAD). * Be able to tolerate oral medication. * Not be pregnant or breast-feeding. * Sign and date an informed consent form.